SCHEMBL24859554

SCHEMBL24859554

CN1CCC[C@@]2(CCNC2=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTUD7B Q6GQQ9 1/20 0.50
GRIN1 Q05586 2/20 0.36
GRIN2A Q12879 2/20 0.36
GRIN2B Q13224 1/20 0.36
CDK8 P49336 6/20 0.34
CCNC P24863 5/20 0.34
USP2 O75604 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
JAK1 P23458 2/20 0.33
TYK2 P29597 2/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
CDK19 Q9BWU1 3/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
LRRK2 Q5S007 1/20 0.32
GSK3A P49840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14377176 1.00 OTUD7B (0.50) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL16750994 0.93 OTUD7B (0.42) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL20414626 0.89 OTUD7B (0.57) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL13879320 0.89 OTUD7B (0.57) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL22172615 0.89 OTUD7B (0.57) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL25049525 0.84 USP2 (0.34) OTUD7BUSP2CYP2D6CYP2C9TSHR
SCHEMBL26374604 0.84 USP2 (0.34) OTUD7BUSP2CYP2D6CYP2C9TSHR
SCHEMBL23260107 0.83 OTUD7B (0.49) OTUD7BGRIN1GRIN2AGRIN2BCDK8
SCHEMBL23707125 0.79 OTUD7B (0.50) OTUD7BGRIN1GRIN2AGRIN2BACACB
SCHEMBL23707127 0.79 OTUD7B (0.50) OTUD7BGRIN1GRIN2AGRIN2BACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548890-B1 HPK1 antagonists and uses thereof Nimbus Saturn, Inc. (US) 2023-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11548890-B1 HPK1 antagonists and uses thereof PDXK, HIPK1, PCK1 OTUD7B 805/4885GRIN1 3676/4885GRIN2A 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.